The present invention is a compound having the general formula (I), (II), or (III) or a pharmacologically acceptable salt, solvate, or hydrate thereof, and a pharmaceutical composition containing such a compound, or its pharmacologically acceptable ester, or other pharmacologically acceptable derivative thereof as an active ingredient. The compound has an excellent ACAT 2-inhibiting activity by a mechanism different from that of a statin drug and is useful as a therapeutic or prophylactic agent for obesity, adiposis, hyperlipidemia, hypercholesterolemia, disorder of lipid metabolism, and arteriosclerosis, as well as obesity-derived hyperlipidemia, hypercholesterolemia, disorder of lipid metabolism, arteriosclerosis, and hypertension.
本发明涉及具有一般式(I)、(II)或(III)或其药理学上可接受的盐、溶剂或
水合物的化合物,以及含有此类化合物或其药理学上可接受的
酯或其他药理学上可接受的衍
生物作为活性成分的制药组合物。该化合物通过与他汀药物不同的机制具有优异的ACAT 2抑制活性,并可用作治疗或预防肥胖症、
脂肪肥大症、高脂血症、高
胆固醇血症、脂质代谢紊乱和动脉硬化的治疗或预防剂,以及肥胖引起的高脂血症、高
胆固醇血症、脂质代谢紊乱、动脉硬化和高血压。